LC-MS/MS 工具检测肠杆菌目细菌耐药机制的性能评估
本研究评估了一种基于液相色谱串联质谱(LC-MS/MS)的多反应监测方法,用于直接同步检测肠杆菌目细菌中13种耐药酶。研究纳入357株肠杆菌目分离株(含292株碳青霉烯酶产生株),经短读长测序确定耐药基因组。结果显示该法对KPC、NDM、VIM、IMP、OXA-48型碳青霉烯酶及CTX-M型ESBL等灵敏度>95%,特异性近100%,但对GES型酶和RmtB/C型甲基化酶灵敏度较低。
要点
- LC-MS/MS法对主要碳青霉烯酶(KPC、NDM、VIM、IMP、OXA-48型)检测灵敏度>95%。
- 对CTX-M型ESBL、CMY-2/DHA型AmpC、Aac(3)-II/Aac(6')-Ib型AME及ArmA甲基化酶灵敏度>95%。
- 对GES型ESBL/碳青霉烯酶和RmtB/C型甲基化酶灵敏度分别仅66.7%和44.4%。
核心结论
- LC-MS/MS法对多种临床相关耐药机制(包括主要碳青霉烯酶类型)表现良好,在碳青霉烯酶产生肠杆菌参考中心具有应用价值。
- 仍需进一步研究(其他细菌种群、耐药机制及临床样本)以明确其完整诊断潜力。
研究设计与样本
- 评估LC-MS/MS多反应监测法直接同步检测13种耐药酶。
- 纳入357株肠杆菌目分离株(主要来自波兰医院2000-23年),其中292株为碳青霉烯酶产生株。
- 分离株经短读长测序确定耐药基因组并测定MIC。
主要发现
- 分离株中目标耐药基因数为1128(不含缺陷和重复拷贝)。
- LC-MS/MS对KPC、NDM、VIM、IMP、OXA-48型碳青霉烯酶、CTX-M型ESBL、CMY-2/DHA型AmpC、Aac(3)-II/Aac(6')-Ib型AME及ArmA甲基化酶灵敏度>95%。
- 对GES型ESBL/碳青霉烯酶灵敏度66.7%,对RmtB/C型甲基化酶灵敏度44.4%。
- 所有检测酶的特异性接近100%。
临床怎么用
- 该法可用于碳青霉烯酶产生肠杆菌参考中心routine实践中快速同步检测多种耐药酶。
- 对GES型酶和RmtB/C型甲基化酶检测灵敏度较低,需注意假阴性可能。
局限性
- 需进一步研究其他细菌种群、耐药机制及临床样本以明确完整诊断潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess a new MS approach in detection of antimicrobial resistance (AMR) mechanisms in Enterobacterales and its usefulness in the routine practice of a national reference centre for carbapenemase-producing enterobacteria (CPE). METHODS: A tool utilizing LC coupled with tandem MS (LC-MS/MS) in multiple reaction monitoring mode was tested in the direct and concurrent detection of 13 AMR enzymes. These comprised carbapenemases, extended-spectrum β-lactamases (ESBLs), AmpC-like cephalosporinases, aminoglycoside-modifying enzymes (AMEs) and 16S rRNA methylases. The study included 357 Enterobacterales isolates largely from Polish hospitals (2000-23), including 292 CPE, collected by the National Reference Centre for Susceptibility Testing. The isolates were short-read sequenced to determine their resistomes, and subjected to MIC evaluation. RESULTS: The number of target AMR genes in the isolates was 1128 without defective and duplicated copies. When possible to deduce, the MIC patterns indicated activity of most of the genes/enzymes. The LC-MS/MS assay showed >95% sensitivity in the identification of KPC-, NDM-, VIM-, IMP- and OXA-48-type carbapenemases, CTX-M-like ESBLs, CMY-2- and DHA-type AmpCs, Aac(3)-II- and Aac(6')-Ib-like AMEs and the ArmA 16S rRNA methylase, but only 66.7% and 44.4% of GES-type ESBLs/carbapenemases and RmtB/C-like methylases, respectively. Detection specificity was almost 100% for all of the enzymes. CONCLUSIONS: The study demonstrated good performance of the assay against multiple clinically-relevant AMR mechanisms, including main carbapenemase types, and its usefulness in a CPE reference centre was confirmed. However, further studies, e.g. with other bacterial populations, AMR mechanisms and clinical samples, are necessary to characterize its full diagnostic potential.
引用
- Witkowska A, Biedrzycka M, Izdebski R, et al. Assessment of an LC coupled with tandem MS (LC-MS/MS) tool in the detection of antimicrobial resistance mechanisms in Enterobacterales. J Antimicrob Chemother. 2025. PMID: 40990142. doi:10.1093/jac/dkaf339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。